Seeking Alpha

AGIO
  Agios Pharmaceuticals, Inc. - NASDAQ

10/23/2014, 7:05 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
AGIO vs. ETF Alternatives
Company Description
Agios Pharmaceuticals Inc is engaged in the development of medicines to treat the cancer metabolism and inborn errors of metabolism, which are a subset of orphan genetic metabolic diseases.
Sector: Healthcare
Industry: Biotechnology
Country: United States